Insider · CIK 0001241359
Edward M Gillis
Files at BCDA (BioCardia, Inc.). First filing Dec 26, 2024, latest Dec 26, 2024.
In brief
Edward M Gillis files SEC Form 4 as officer at BCDA (BioCardia, Inc.). Since Dec 26, 2024, Edward M Gillis has reported 0 open-market buys worth $0 and 1 open-market sell worth $6,514, the latest filed on Dec 26, 2024.
A track record needs three past buys with six months of prices behind them; Edward M Gillis has 0, so none is measured yet.
The newest scored trade: sold $6,514 of BCDA on Dec 20, 2024, filed Dec 26, 2024, scored 25 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BCDA: BioCardia, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 17, 2024 | BCDA BioCardia, Inc. | 3,257 0.07% of outstanding | $6,611 | Dec 17, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | BCDA BioCardia, Inc. | FTax withholding Common Stock | -17,269 | $1.24 | $21k | 54,126 | Jul 7, 2026 |
| Jul 6, 2026 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +29,442 | $0.00 | $0 | 61,139 | Jul 7, 2026 |
| Jun 29, 2026 | BCDA BioCardia, Inc. | AGrant or award Common Stock | +39,521 | $1.20 | $47k | 71,395 | Jul 1, 2026 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Common Stock | +38,078 | $1.37 | $52k | 47,046 | Dec 10, 2025 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | FTax withholding Common Stock | +15,172 | $1.37 | $21k | 31,874 | Dec 10, 2025 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 31,697 | Dec 10, 2025 |
| Dec 20, 2024 | BCDA BioCardia, Inc. | SOpen-market sale Common Stock | -3,257 | $2.00 | $6,514 | 8,968 | Dec 26, 2024 |
| Oct 11, 2024 | BCDA BioCardia, Inc. | AGrant or award Common Stock | -15,808 | $2.65 | $42k | 19,065 | Oct 16, 2024 |
| Oct 11, 2024 | BCDA BioCardia, Inc. | FTax withholding Common Stock | -6,840 | $2.65 | $18k | 12,225 | Oct 16, 2024 |
Questions about Edward M Gillis
Answered from the filings on this page, as of the latest one.
Is Edward M Gillis buying or selling?
Not in the last 12 months. Edward M Gillis's latest open-market trade on SEC Form 4 was sold $6,514 of BCDA on Dec 20, 2024.
How did Edward M Gillis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Edward M Gillis has 0.
Where does Edward M Gillis file Form 4?
Edward M Gillis has filed Form 4 at BCDA (BioCardia, Inc.) as Senior Vice President, Devices. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.